Angiographic outcomes (PUFS and ASPIRe only)a
| Follow-Up | Statin Use | No Statin Use | P Value |
|---|---|---|---|
| Complete occlusion at 180 days (−20/+42 days) | 84.8% (28/33) | 72.2% (83/115) | .174 |
| Complete occlusion at 1 year (±42 days) | 82.8% (24/29) | 86.4% (70/81) | .759 |
| Complete occlusion at 3 years | 94.7% (18/19) | 93.0% (53/57) | 1.000 |
| Complete occlusion at 5 years | 93.3% (14/15) | 95.7% (45/47) | 1.000 |
| Complete occlusion at last follow-up visit | 76.4% (42/55) | 83.8% (129/154) | .227 |
↵a Analysis was performed with the Pearson χ2 test.